MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
AU698699B2
(en)
*
|
1993-11-22 |
1998-11-05 |
Pharmacia & Upjohn Company |
Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
BR9509673A
(pt)
*
|
1994-11-15 |
1997-09-30 |
Upjohn Co |
Compostos e uso dos mesmos
|
KR100441334B1
(ko)
*
|
1995-02-03 |
2004-10-20 |
파마시아 앤드 업존 캄파니 |
헤테로-방향족고리치환된페닐옥사졸리딘온항균제
|
MX9708627A
(es)
*
|
1995-05-11 |
1998-02-28 |
Upjohn Co |
Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas.
|
CN1072222C
(zh)
*
|
1995-09-01 |
2001-10-03 |
法玛西雅厄普约翰公司 |
以c-c键连接于4-8元杂环环的苯基噁唑烷酮
|
US5883093A
(en)
*
|
1995-09-12 |
1999-03-16 |
Pharmacia & Upjohn Company |
Phenyloxazolidinone antimicrobials
|
AU6964096A
(en)
*
|
1995-09-15 |
1997-04-01 |
Pharmacia & Upjohn Company |
Aminoaryl oxazolidinone n-oxides
|
ZA968661B
(en)
*
|
1995-11-17 |
1998-04-14 |
Upjohn Co |
Oxazolidinone antibacterial agent with tricyclic substituents.
|
ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
*
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
DE69709718T2
(de)
*
|
1996-04-11 |
2002-06-20 |
Upjohn Co |
Verfahren zur herstellung von oxazolidinonen
|
AT403803B
(de)
|
1996-04-19 |
1998-05-25 |
Sanochemia Ltd |
Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
|
GB9609919D0
(en)
*
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9614236D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
GB9614238D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
KR100307211B1
(ko)
*
|
1997-05-24 |
2001-11-30 |
손 경 식 |
옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
|
US6037354A
(en)
*
|
1997-06-18 |
2000-03-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
EP0994874A1
(de)
*
|
1997-07-11 |
2000-04-26 |
PHARMACIA & UPJOHN COMPANY |
Thiadiazolyl und oxadiazolyl phenyl oxazolidinone als antibakterielle mittel
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
KR100467309B1
(ko)
*
|
1997-09-04 |
2005-07-18 |
씨제이 주식회사 |
옥사졸리디논유도체및그의제조방법및항균제조성물
|
KR100463111B1
(ko)
*
|
1997-10-30 |
2005-06-13 |
씨제이 주식회사 |
신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
|
CN101353313A
(zh)
*
|
1997-11-07 |
2009-01-28 |
法玛西雅厄普约翰美国公司 |
制备唑烷酮的方法
|
CA2303959A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions
|
ES2193592T3
(es)
*
|
1997-11-18 |
2003-11-01 |
Upjohn Co |
Uso de derivados de la oxazolidinona para el tratamiento de la artritis.
|
US6040306A
(en)
*
|
1997-11-18 |
2000-03-21 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
ES2243650T3
(es)
*
|
1997-11-18 |
2005-12-01 |
PHARMACIA & UPJOHN COMPANY LLC |
Uso de derivados de oxazolidinonas para el tratamiento de la psoriasis.
|
AU780197B2
(en)
*
|
1997-11-18 |
2005-03-10 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
CA2318969A1
(en)
|
1998-01-23 |
1999-07-29 |
Mikhail F. Gordeev |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
NZ506292A
(en)
*
|
1998-02-13 |
2003-05-30 |
Upjohn Co |
Substituted aminophenyl isoxazoline methylamide derivatives useful as antimicrobials
|
GB9812019D0
(en)
*
|
1998-06-05 |
1998-07-29 |
Zeneca Ltd |
Chemical compounds
|
EE200000707A
(et)
|
1998-06-05 |
2002-04-15 |
Astrazeneca Ab |
Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
|
CN1129581C
(zh)
*
|
1998-09-22 |
2003-12-03 |
山之内制药株式会社 |
氰基苯基衍生物
|
AU764980B2
(en)
*
|
1998-11-27 |
2003-09-04 |
Pharmacia & Upjohn Company |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
JP2002535680A
(ja)
|
1999-01-27 |
2002-10-22 |
ファルマシア・アンド・アップジョン・カンパニー |
延長因子p活性モジュレーターのアッセイ方法
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
NZ516853A
(en)
|
1999-07-28 |
2003-11-28 |
Upjohn Co |
Oxazolidinones and their use as anti-infectives
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
AR027261A1
(es)
*
|
2000-02-02 |
2003-03-19 |
Upjohn Co |
Linezolid forma cristalina ii
|
US6642238B2
(en)
|
2000-02-10 |
2003-11-04 |
Pharmacia And Upjohn Company |
Oxazolidinone thioamides with piperazine amide substituents
|
US6514529B2
(en)
*
|
2000-03-22 |
2003-02-04 |
Pharmacia & Upjohn Company |
Oxazolidinone tablet formulation
|
MY127336A
(en)
|
2000-03-22 |
2006-11-30 |
Upjohn Co |
Container for linezolid iv solution
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
AU5889701A
(en)
*
|
2000-06-05 |
2001-12-17 |
Dong A Pharm Co Ltd |
Novel oxazolidinone derivatives and a process for the preparation thereof
|
EP1301207B1
(de)
|
2000-06-30 |
2005-08-10 |
Pharmacia & Upjohn Company LLC |
Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten
|
JP2004504321A
(ja)
*
|
2000-07-17 |
2004-02-12 |
ランバクシー ラボラトリーズ リミテッド |
抗微生物剤としてのオキサゾリジノン誘導体
|
WO2003008389A1
(en)
*
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
EP1328509B1
(de)
|
2000-10-17 |
2006-03-22 |
Pharmacia & Upjohn Company LLC |
Verfahren zur herstellung von oxazolidinonverbindungen
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
ES2186550B2
(es)
*
|
2001-06-27 |
2003-11-16 |
Vita Lab |
Nuevos derivados de oxazolidinonas como antibacterianos.
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
SI1427711T1
(sl)
|
2001-09-11 |
2005-12-31 |
Astrazeneca Ab |
Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
|
US20050043374A1
(en)
*
|
2001-10-25 |
2005-02-24 |
Gravestock Michael Barry |
Aryl substituted oxazolidinones with antibacterial activity
|
EP1443930A1
(de)
|
2001-10-25 |
2004-08-11 |
AstraZeneca AB |
Isoxazolinderivative verwendbar als antimikrobielle agenzien
|
TW200302095A
(en)
*
|
2002-01-25 |
2003-08-01 |
Upjohn Co |
Oxazolidinone cotherapy
|
JP2005519931A
(ja)
*
|
2002-02-05 |
2005-07-07 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
細菌感染症治療に有用な抗微生物性チアジアジノン誘導体
|
US7141588B2
(en)
*
|
2002-02-25 |
2006-11-28 |
Pfizer, Inc. |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
AR038536A1
(es)
*
|
2002-02-25 |
2005-01-19 |
Upjohn Co |
N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
|
RU2354372C2
(ru)
*
|
2002-03-29 |
2009-05-10 |
Фармация Энд Апджон Компани Ллс |
Парентеральное, внутривенное и пероральное введение оксазолидинонов для лечения инфекционных поражений стопы при диабете
|
US20060229316A1
(en)
*
|
2002-04-01 |
2006-10-12 |
Lohray Braj B |
Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
|
BR0310074A
(pt)
*
|
2002-05-15 |
2005-03-08 |
Ranbaxy Lab Ltd |
Formas polimórficas de derivados de fenil oxazolidinona
|
CN1668308A
(zh)
*
|
2002-07-29 |
2005-09-14 |
兰贝克赛实验室有限公司 |
作为抗菌剂的噁唑烷酮衍生物
|
EP1539745B1
(de)
*
|
2002-08-12 |
2006-03-29 |
Pharmacia & Upjohn Company LLC |
N-aryl-2-oxazolidinone und deren derivate
|
US20070167414A1
(en)
*
|
2002-08-22 |
2007-07-19 |
Orchid Chemicals & Pharmaceuticals Limited |
Novel antibacterial agents
|
EP1578734A1
(de)
*
|
2002-08-22 |
2005-09-28 |
Orchid Chemicals and Pharmaceuticals Ltd |
Neue antibakterielle wirkstoffe
|
WO2004026848A1
(en)
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
US6875784B2
(en)
|
2002-10-09 |
2005-04-05 |
Pharmacia & Upjohn Company |
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
|
JP2006504726A
(ja)
|
2002-10-10 |
2006-02-09 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
抗菌性1−アリールジヒドロピリドン化合物
|
AU2003280143A1
(en)
*
|
2002-11-21 |
2004-06-15 |
Pharmacia & Upjohn Company Llc |
N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
|
AU2002357561A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Nanjing Chang'ao Pharmaceutical Science And Technology Limited Company |
Oxazolidine derivative, methods of preparation and uses
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
BRPI0407304A
(pt)
*
|
2003-02-07 |
2006-01-10 |
Warner Lambert Co |
Agentes antibacterianos
|
BRPI0407252A
(pt)
*
|
2003-02-07 |
2006-01-31 |
Warner Lambert Co |
Agentes antibacterianos.
|
US20040204463A1
(en)
*
|
2003-04-01 |
2004-10-14 |
Harris Christina Renee |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
EP1620433A1
(de)
*
|
2003-04-07 |
2006-02-01 |
Ranbaxy Laboratories, Ltd. |
Oxazolidinon-derivate als antimikrobielle mittel
|
WO2004113329A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Orchid Chemicals And Pharmaceuticals Ltd. |
Oxazole derivatives as antibacterial agents
|
BRPI0413838A
(pt)
*
|
2003-08-25 |
2006-10-24 |
Warner Lambert Co |
compostos de ariloxazolidinona antimicrobianos
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
US7304050B2
(en)
*
|
2003-09-16 |
2007-12-04 |
Pfizer Inc. |
Antibacterial agents
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
WO2005051933A1
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
WO2005113520A1
(en)
*
|
2004-05-20 |
2005-12-01 |
Pharmacia & Upjohn Company Llc |
Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
|
EP1658275A1
(de)
*
|
2004-06-29 |
2006-05-24 |
Teva Pharmaceutical Industries Ltd |
Kristalline form iv von linezolid
|
US20090247545A1
(en)
*
|
2004-10-11 |
2009-10-01 |
Mukund Keshao Gurjar |
Substituted oxazolidinone derivatives
|
EP1685841A1
(de)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
EP1866295A2
(de)
*
|
2005-02-24 |
2007-12-19 |
Teva Pharmaceutical Industries Ltd |
Verfahren zur herstellung von linezolidzwischenprodukten
|
EP1874782A1
(de)
|
2005-04-15 |
2008-01-09 |
Ranbaxy Laboratories Limited |
Oxazolidinon-derivate als antimikrobielle mittel
|
ES2335307T3
(es)
|
2005-06-29 |
2010-03-24 |
PHARMACIA & UPJOHN COMPANY LLC |
Homomorfolin oxalidinonas como agentes antibacterianos.
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
RU2429236C2
(ru)
|
2005-10-04 |
2011-09-20 |
Байер Шеринг Фарма Акциенгезельшафт |
Новая полиморфная форма и аморфная форма 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолинил)-фенил]-1, 3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида
|
WO2008010070A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Orchid Research Laboratories Limited |
Novel oxazolidinone derivatives
|
US7593630B2
(en)
|
2006-07-24 |
2009-09-22 |
Foxconn Technology Co., Ltd. |
Built-in multidriver device for a camera zoom lens
|
US20100298384A1
(en)
*
|
2006-12-04 |
2010-11-25 |
Mohamed Takhi |
Novel oxazolidinone compounds as antiinfective agents
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
US20090093631A1
(en)
*
|
2007-09-06 |
2009-04-09 |
Ben-Zion Dolitzky |
Processes for the preparation of a linezolid intermediate, linezolid hydroxide
|
CA2712613C
(en)
*
|
2008-03-26 |
2017-02-28 |
Global Alliance For Tb Drug Development |
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
|
EP2138178A1
(de)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninone zur Behandlung der chronisch obstruktiven Lungenerkrankung (COPD) und/oder Asthma
|
EP2140866A1
(de)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinone zur Behandlung von Entzündungserkrankungen des Magen-Darm-Trakts
|
EP2757104B1
(de)
|
2008-10-10 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
In der synthese von oxazolidinonen verwendete verbindungen
|
JP5478499B2
(ja)
*
|
2008-10-27 |
2014-04-23 |
田辺三菱製薬株式会社 |
新規アミド誘導体およびその医薬としての用途
|
CA2743971A1
(en)
*
|
2008-11-20 |
2010-05-27 |
Panacea Biotec Ltd. |
Novel antimicrobials
|
CU24089B1
(es)
|
2009-02-03 |
2015-04-29 |
Trius Therapeutics |
Forma cristalina del fosfato de dihidrógeno r)-3-(4-(2-(2-metiltretazol-5-il)-3-fluorofenil)-5-hidroximetil oxazolidin-2-ona
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
CN103360379B
(zh)
*
|
2012-03-31 |
2017-05-24 |
南京圣和药业股份有限公司 |
噁唑烷酮化合物
|
WO2017156519A1
(en)
|
2016-03-11 |
2017-09-14 |
The Board Of Trustees Of The University Of Illinois |
Small-molecules active against gram-negative bacteria
|
US11274106B2
(en)
|
2017-06-23 |
2022-03-15 |
The Board Of Trustees Of The University Of Illinois |
Topoisomerase inhibitors with antibacterial and anticancer activity
|
KR20210038632A
(ko)
|
2018-07-25 |
2021-04-07 |
카딜라 핼쓰캐어 리미티드 |
포유류 감염 치료를 위한 신규 화합물
|
CN110372624A
(zh)
*
|
2019-08-13 |
2019-10-25 |
北京海美桐医药科技有限公司 |
一种噁唑烷酮类化合物、其制备方法及应用
|
WO2021184339A1
(en)
*
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|